Prelude Therapeutics Incorporated (PRLD) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Prelude Therapeutics Incorporated, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$4.14
+6.70% today
Market cap
$310M
Overall quality
—
Kronos AI 30-day
+3.4%
8 of 8 simulated paths end higher
Prelude Therapeutics Incorporated (PRLD) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $310M. It trades at $4.14, up 6.70% today. 2 analysts' average target of $10.00 implies +141.5% from today's price. Kronos AI's 30-day forecast is +3.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $8.00 – $12.00 |
| Analysts | 2 |
| Upside to average | +141.5% |
Kronos AI 30-day forecast
| Expected close | $4.01 (+3.4%) |
| Likely range | +0.9% … +18.0% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.